Sano Genetics

Sano Genetics is a biotechnology research company dedicated to accelerating the future of personalised medicine. Founded in 2017 by Dr. Patrick Short, Charlotte Guzzo, and William Jones, who met during their PhDs at the University of Cambridge, the company was born from their shared vision to improve the process of medical research. Experiencing the inefficiencies of clinical trials from both a researcher and participant perspective, they established Sano Genetics to create a more human-centric and efficient approach. The company's core mission is to connect individuals directly with research studies, empowering them to contribute to scientific advancements on their own terms. Sano's platform is designed to streamline every step of the research process, from patient recruitment and genetic testing to long-term engagement and data analysis. This integrated approach addresses major bottlenecks in clinical trials, which are often delayed or fail due to difficulties in finding and retaining participants.

The platform offers a seamless, digital experience for participants, who can join studies from the comfort of their homes, often at no cost. By providing at-home DNA testing kits and a user-friendly interface, Sano Genetics removes many of the traditional barriers to research participation. A key pillar of the company's philosophy is data privacy and transparency; participants maintain full control over their genetic data, with the ability to provide explicit consent for its use in specific studies and to withdraw at any time. Sano Genetics works with a wide range of partners, including pharmaceutical companies, biotechs, population genomics initiatives, and patient advocacy groups. By facilitating faster, more cost-effective, and more inclusive research, the company is helping to accelerate the development of new treatments for a variety of conditions, including rare diseases like motor neurone disease (MND) and more common disorders such as Parkinson's, multiple sclerosis, and Long COVID. Through its innovative model, Sano Genetics is not only advancing precision medicine but also fostering a more engaged and empowered community of research participants.